Navigation Links
New AHRQ Resources Help Primary Care Clinicians Treat Alcohol Use Disorder
Date:2/16/2016

ROCKVILLE, Md., Feb. 16, 2016 /PRNewswire-USNewswire/ -- The Agency for Healthcare Research and Quality (AHRQ) today published two new resources to help primary care clinicians and their patients make evidence-based decisions about which medications to use for treating alcohol use disorder (AUD), the medical diagnosis for problem drinking that causes mild to severe distress or harm.

The new resources – a pair of research summaries designed to facilitate treatment discussions between clinicians and patients – will make it easier for primary care clinicians to work with their patients to make treatment decisions about medications used to treat AUD. Primary care providers are typically trained to refer patients with AUD for specialized treatment, and fewer than 10 percent of people treated for AUD receive medications currently.

In the United States, more than 68 million people 18 years old or older suffer from AUD at some point in their lifetime, according to data released by the National Institute on Alcohol Abuse and Alcoholism in August 2015. The disorder can lead to severe health problems and immeasurable personal and family suffering. It is the third modifiable risk factor that leads to early death, after tobacco use and being overweight; people with AUD are at least three times as likely to die early as those without AUD.

"These new resources, based on the most current research, will help clinicians and patients make informed choices about treatment in accordance with their own wishes and values," said AHRQ Director Rick Kronick, Ph.D.

The research summaries are based on findings from a 2014 review of the evidence on medication-based treatment of AUD. One summary is directed at clinicians and other health care providers to help them understand the evidence currently available so they can apply it on the front lines of care. The other summary is written in a way that can help patients and their families understand what their options are for medication-based treatments.

AHRQ's systematic review found moderate evidence that acamprosate (trade name: Campral) and oral naltrexone (Reviva, Vivitrol) improve outcomes for patients with AUD. Head-to-head comparisons have not consistently established the superiority of one medication over another, and evidence related to injectable naltrexone is limited. The review also found that the evidence from randomized, placebo-controlled trials does not support the effectiveness of disulfiram (Antabuse) for clinical outcomes, such as a return to any drinking and number of drinks/per drinking days, or for reducing amount of alcohol consumed. 

Most studies included in the review evaluated the use of medications in conjunction with psychosocial treatments; the use of medications alone has not been studied enough to draw conclusions, according to the review.

Conducted by researchers funded through AHRQ's Evidence-based Practice Center program, the review included studies on medicines to treat alcohol dependence and alcohol use disorder published between January 1970 and October 2013. The report included 135 studies, and findings were reviewed by health care professionals, researchers, experts and the public. The full report is available at www.effectivehealthcare.ahrq.gov/alcohol-disorder.

AHRQ's Evidence-based Practice Centers develop systematic reviews to help the public, clinicians and others who make decisions about health care improve the quality of care provided in the United States. These reviews provide comprehensive, science-based information on common, costly medical conditions and new health care technologies and strategies. Select findings from these reviews are translated into guides so that clinicians and patients can easily apply the findings on the front lines of care. These new AUD research summaries and other guides and systematic reviews can be found at www.effectivehealthcare.ahrq.gov.

AHRQ's mission is to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work with Department of Health and Human Services and other partners to make sure that the evidence is understood and used. For more information about AHRQ, visit www.ahrq.gov.

 

 


'/>"/>
SOURCE Agency for Healthcare Research & Quality
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Orexigen Therapeutics names Thomas Lynch as EVP, General Counsel & Secretary and Heather Ace as EVP, Global Human Resources
2. Hospice Pharmacy Solutions completes merger with Outcome Resources
3. Sign Against Stroke Task Force Help to Address Medical, Physical, Mental and Financial Needs of People with Atrial Fibrillation with New Health Empowerment Resources
4. West Appoints Annette Favorite Senior Vice President and Chief Human Resources Officer
5. Decision Resources Groups Monique Levy Appointed to Google Healthcare Advisory Board
6. Decision Resources Group Projects the US Market for Diabetes Care Devices To Be Valued at Over $22 Billion by 2023
7. NxStage Launches New Spanish-Language Resources for Hispanic Patients
8. Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance
9. Intarcia Appoints James P. Brady Vice President, Human Resources
10. Precyse Unlocks Revenue and Resources at HIMSS 2015
11. DigiPath Inc. Partners with Blue Line Protection Group to Share Resources and Develop Marketing Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
Breaking Medicine News(10 mins):